Cellectis Files Routine 6-K, Confirms 20-F Reporting
Ticker: CLLS · Form: 6-K · Filed: Jul 25, 2024 · CIK: 1627281
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Cellectis filed a 6-K confirming its 20-F reporting status. No major news.
AI Summary
Cellectis S.A. filed a Form 6-K on July 25, 2024, to report its status as a foreign private issuer. The filing confirms that Cellectis, headquartered in Paris, France, will file its annual reports under Form 20-F. This is a routine filing and does not contain specific financial or operational updates.
Why It Matters
This filing is a standard procedural document for foreign private issuers, indicating Cellectis's compliance with SEC reporting requirements for its fiscal year.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- July 25, 2024 (date) — Filing Date
- Paris, France (location) — Company Headquarters
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Filing
FAQ
What is the purpose of a Form 6-K filing for Cellectis S.A.?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to report information that the company has made or is required to make public in its home country.
When was this Form 6-K filed?
This Form 6-K was filed on July 25, 2024.
Does Cellectis S.A. file its annual reports under Form 20-F or Form 40-F?
Cellectis S.A. indicates it files its annual reports under cover of Form 20-F.
Where is Cellectis S.A. headquartered?
Cellectis S.A. is headquartered at 8, rue de la Croix Jarry, 75013 Paris, France.
Does this filing contain specific financial results or operational updates?
No, this filing is a routine administrative report and does not contain specific financial results or operational updates.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.7 · Accepted 2024-07-25 16:35:08
Filing Documents
- f6k_072524.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 9KB
- 0001171843-24-004152.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: July 25, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer